SEGLUROMET 2.5 mg/1

Segluromet 2.5 mg/1 combines ertugliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Segluromet 2.5 mg/1 is used to help manage type 2 diabetes in adults. It works by improving blood sugar levels, often alongside diet and exercise. This combination medication is designed for those who need additional glycemic control beyond metformin alone.

Common effects of Segluromet 2.5 mg/1 may include symptoms like urinary tract infections, genital mycotic infections, and gastrointestinal discomfort. Individual responses can vary, and not everyone will experience these effects.

Handle Segluromet 2.5 mg/1 with care, especially if you have kidney issues or are at risk for dehydration. Always follow your healthcare provider's guidance regarding its use and monitor for any adverse reactions.

Segluromet 2.5 mg/1 may interact with certain medications, including diuretics, insulin, and other diabetes treatments. It's important to discuss all current medications with your healthcare provider to avoid potential interactions.